Teicoplanin Matches Standard Care With Less Nephrotoxicity in Bacteremia
Analysis Infectious Disease / Antimicrobials Confirmatory Grade: Low
Alawad E, Assiri T, Alharthi M, et al.
Jul 31, 2026 · Published in: Open Forum Infectious Diseases
Teicoplanin matches standard antibiotics but reduces nephrotoxicity risk.
Rapid PCR Testing in Hospital-Acquired Pneumonia
Analysis Infectious Disease / Antimicrobials
Kernéis S, Canouï E, Deconinck L, et al.
Jul 31, 2026 · Published in: JAC-antimicrobial Resistance
Rapid PCR testing aids early antibiotic decision-making in pneumonia.
Antiviral Benefit Uncertain in Vaccinated Omicron-Era COVID-19 Patients
Analysis Infectious Disease / Antimicrobials Inconclusive Grade: Low
Edwards LJ, Liu B, Wood JG, et al.
Jul 31, 2026 · Published in: Open Forum Infectious Diseases
Nirmatrelvir-ritonavir may reduce hospitalization in vaccinated patients.
Genetic Testing Prevents Aminoglycoside-Induced Hearing Loss
Guideline Infectious Disease / Antimicrobials
McDermott JH, Hilton S, Dello Russo C, et al.
Jul 29, 2026 · Published in: British Journal of Clinical Pharmacology
Genetic testing can prevent irreversible hearing loss from antibiotics.
Multisociety Consensus Endorses Beta-Lactam Dose Individualization in Acutely Ill Patients
Consensus Statement Infectious Disease / Antimicrobials Practice-changing Grade: Low
Barreto EF, McCreary EK, Pai Mangalore R, et al.
Jul 23, 2026 · Published in: Pharmacotherapy
New guidelines urge personalized beta-lactam dosing for acutely ill patients.
AGA Expert Review Reframes C difficile Management in IBD
Analysis Infectious Disease / Antimicrobials Confirmatory Grade: Low
Khanna S, Allegretti JR, Hashash JG, et al.
Jul 15, 2026 · Published in: Gastroenterology
CDI poses higher risks for IBD patients, complicating management strategies.
Capsid Inhibitors and Lenacapavir: A Mechanistic and Resistance Review
Analysis Infectious Disease / Antimicrobials Confirmatory Grade: Low
Mahdi M, Lakatos B, Mótyán JA, et al.
Jul 10, 2026 · Published in: PLOS Pathogens
HIV capsid inhibitors could transform HIV treatment strategies.
Pharmacist audit-feedback raises surgical prophylaxis compliance in Vietnam
Analysis Infectious Disease / Antimicrobials Confirmatory Grade: Low
Nguyen DT, Tran SN, Nguyen TTH, et al.
Jun 26, 2026 · Published in: PLOS One
Pharmacist-led interventions boost antibiotic compliance in surgery.
ECIL-10 Reshapes Febrile Neutropenia Antibiotic Strategy Around Stewardship
Guideline Infectious Disease / Antimicrobials Practice-changing Grade: Moderate
Averbuch D, Vanbiervliet Y, Baccelli F, et al.
Jun 25, 2026 · Published in: The Lancet. Infectious Diseases
Rising resistance challenges febrile neutropenia treatment in hematologic patients.
Framework Proposed to Pair New Tuberculosis Drugs With Resistance Diagnostics
Analysis Infectious Disease / Antimicrobials Hypothesis-generating Grade: Very Low
Saluzzo F, Yerlikaya S, Dorman SE, et al.
Jun 23, 2026 · Published in: The Lancet. Infectious Diseases
Rising resistance threatens tuberculosis treatment efficacy.
Cefiderocol Matches Standard Care in Gram-Negative Bloodstream Infection
Analysis Infectious Disease / Antimicrobials Confirmatory Grade: Moderate
Paterson DL, Sulaiman H, Liu PY, et al.
Jan 1, 2026 · Published in: Lancet Infectious Diseases
The first randomised trial dedicated to cefiderocol for hospital-acquired and health-care-associated Gram-negative bloodstream infection shows non-inferiority but no superiority, with a concerning mortality signal in metallo-beta-lactamase producers.